Virtus ETF Advisers’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Virtus ETF Advisers’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,481	Closed	-$216K	–	495
2023 Q4	$216K	Buy	+3,481	New	+$86.5K	0.14%	269

Virtus ETF Advisers's RYZB Position: Q1 2024 in Review

Virtus ETF Advisers sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 3,481 shares — an estimated $216K sold.

Virtus ETF Advisers first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $216K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Virtus ETF Advisers reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Virtus ETF Advisers sold 3,481 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $216K.
Virtus ETF Advisers first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Virtus ETF Advisers's RayzeBio, Inc. Common Stock position peaked at $216K in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Virtus ETF Advisers's 13F filing for Q1 2024, filed 15 May 2024.